166 related articles for article (PubMed ID: 8396223)
21. Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas.
Lania A; Mantovani G; Ferrante E; Zavanone LM; Locatelli M; Corbetta S; Beck-Peccoz P; Spada A
J Endocrinol Invest; 2004 Apr; 27(4):328-33. PubMed ID: 15233551
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of stimulatory G protein alpha-subunit is a hallmark of most human somatotrophic pituitary tumours and is associated with resistance to GH-releasing hormone.
Hamacher C; Bröcker M; Adams EF; Lei T; Fahlbusch R; Buchfelder M; Derwahl M
Pituitary; 1998 Apr; 1(1):13-23. PubMed ID: 11081179
[TBL] [Abstract][Full Text] [Related]
23. Relationship between protein kinase C and adenylyl cyclase activity in the regulation of growth hormone secretion by human pituitary somatotrophinomas.
Lei T; Adams EF; Buchfelder M; Fahlbusch R
Neurosurgery; 1996 Sep; 39(3):569-75; discussion 575-6. PubMed ID: 8875488
[TBL] [Abstract][Full Text] [Related]
24. Acromegaly in a family without a mutation in the menin gene.
Ackermann F; Krohn K; Windgassen M; Buchfelder M; Fahlbusch R; Paschke R
Exp Clin Endocrinol Diabetes; 1999; 107(1):93-6. PubMed ID: 10077364
[TBL] [Abstract][Full Text] [Related]
25. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
[TBL] [Abstract][Full Text] [Related]
26. [Genetic changes in human pituitary adenomas].
Spada A; Lania A
Minerva Endocrinol; 2003 Mar; 28(1):27-37. PubMed ID: 12621361
[TBL] [Abstract][Full Text] [Related]
27. TPA enhances growth hormone (GH) secretion effect of GH-releasing hormone (GHRH) by human gsp-positive pituitary somatotrophinomas.
Lei T; Bai X; Hu W; Xue D; Jiang X
J Tongji Med Univ; 1999; 19(3):237-9, 248. PubMed ID: 12840904
[TBL] [Abstract][Full Text] [Related]
28. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.
Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C
J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434
[TBL] [Abstract][Full Text] [Related]
29. G protein abnormalities in pituitary adenomas.
Spada A; Lania A; Ballarè E
Mol Cell Endocrinol; 1998 Jul; 142(1-2):1-14. PubMed ID: 9783897
[TBL] [Abstract][Full Text] [Related]
30. Activating mutations of the Gs alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors.
Ballaré E; Mantovani S; Lania A; Di Blasio AM; Vallar L; Spada A
J Clin Endocrinol Metab; 1998 Dec; 83(12):4386-90. PubMed ID: 9851782
[TBL] [Abstract][Full Text] [Related]
31. Clinical and biochemical characteristics of growth hormone-secreting pituitary tumors.
Bai X; Lei T; Liu K
J Tongji Med Univ; 2000; 20(3):212-3. PubMed ID: 11215051
[TBL] [Abstract][Full Text] [Related]
32. Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission.
Freda PU; Chung WK; Matsuoka N; Walsh JE; Kanibir MN; Kleinman G; Wang Y; Bruce JN; Post KD
Pituitary; 2007; 10(3):275-82. PubMed ID: 17594522
[TBL] [Abstract][Full Text] [Related]
33. Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis.
Yoshimoto K; Iwahana H; Fukuda A; Sano T; Itakura M
Cancer; 1993 Aug; 72(4):1386-93. PubMed ID: 8339229
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior.
Thapar K; Kovacs K; Stefaneanu L; Scheithauer B; Killinger DW; Lioyd RV; Smyth HS; Barr A; Thorner MO; Gaylinn B; Laws ER
Am J Pathol; 1997 Sep; 151(3):769-84. PubMed ID: 9284826
[TBL] [Abstract][Full Text] [Related]
35. G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas.
Williamson EA; Ince PG; Harrison D; Kendall-Taylor P; Harris PE
Eur J Clin Invest; 1995 Feb; 25(2):128-31. PubMed ID: 7737262
[TBL] [Abstract][Full Text] [Related]
36. Genetic and Epigenetic Characterization of Growth Hormone-Secreting Pituitary Tumors.
Välimäki N; Schalin-Jäntti C; Karppinen A; Paetau A; Kivipelto L; Aaltonen LA; Karhu A
Mol Cancer Res; 2019 Dec; 17(12):2432-2443. PubMed ID: 31578227
[TBL] [Abstract][Full Text] [Related]
37. GNAS imprinting and pituitary tumors.
Mantovani G; Lania AG; Spada A
Mol Cell Endocrinol; 2010 Sep; 326(1-2):15-8. PubMed ID: 20398730
[TBL] [Abstract][Full Text] [Related]
38. G-protein oncogenes in acromegaly.
Spada A; Vallar L
Horm Res; 1992; 38(1-2):90-3. PubMed ID: 1306524
[TBL] [Abstract][Full Text] [Related]
39. Expression of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene.
Peri A; Conforti B; Baglioni-Peri S; Luciani P; Cioppi F; Buci L; Corbetta S; Ballaré E; Serio M; Spada A
J Clin Endocrinol Metab; 2001 May; 86(5):2111-7. PubMed ID: 11344215
[TBL] [Abstract][Full Text] [Related]
40. MEG3 is associated with gsp oncogene regulation of growth hormone hypersecretion, proliferation and invasiveness of human GH-secreting adenomas.
Tang C; Zhong C; Cong Z; Yang J; Wen G; Zhu J; Ma C
Oncol Lett; 2019 Mar; 17(3):3495-3502. PubMed ID: 30867789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
